News & Blogs

ImmuLINK® Panel ID Algorithm is NOW LAUNCHED!

Are you feeling the pressure of inspections, staff compliance with SOPs, and maintaining competency in antibody identification workups? Are there risks of clerical errors or oversights in your laboratory? Are antibody identification referrals straining your budget? Empower your staff, reduce […]

Werfen acquires Omixon

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for […]

NEW and Definitely Improved!

You deserve exceptional service/support and our NEW Customer Centre is a testament to our commitment to your satisfaction. This innovative platform serves as a hub where you can access a wide range of resources, tools, and services to enhance your […]

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

Corporate Social Responsibility

Immucor is dedicated to supporting our global and local communities and environments through the giving of our time, talents and money in order to transform a life. With sites located throughout the world, Immucor provides the support needed for all […]